Documents

Federal rules and notices from the public comment record, analyzed continuously.

Most commented Most recentOpen for comment

Agency ▾

IFR Altitudes; Miscellaneous AmendmentsFAARule
0 comments
U.S. DOT/FAA - Acknowledgement LetterFAAOther
0 comments
U.S. DOT/FAA - DecisionFAAOther
0 comments
U.S. DOT/FAA - DecisionFAAOther
0 comments
U.S. DOT/FAA - Acknowledgement LetterFAAOther
0 comments
U.S. DOT/FAA - DecisionFAAOther
0 comments
Tri-State Precision Applicators LLC - Exemption/RulemakingFAAOther
0 comments
Agency Information Collection Activities: Requests for Comments; Clearance of Renewed Approval of Information Collection: FAA Aircraft Noise Complaint and Inquiry System (Noise Portal)FAANotice
0 comments
U.S. DOT/FAA - DecisionFAAOther
0 comments
Ratio Drones Inc. - Letter of IntentFAAOther
0 comments
Airspace Designations and Reporting Points: Class E Airspace; Springfield, KY; CorrectionFAARule
0 comments
Airspace Designations and Reporting Points: Crown Point, INFAARule
0 comments
Airworthiness Directives: The Boeing Company AirplanesFAAProposed Rule
0 comments
Airworthiness Directives: General Electric Company EnginesFAAProposed Rule
0 comments
U.S. DOT/FAA - Supplemental AD DocumentsFAASupporting & Related Material
0 comments
U.S. DOT/FAA - DecisionFAAOther
0 comments
U.S. DOT/FAA - Request for InformationFAAOther
0 comments
U.S. DOT/FAA - Request for InformationFAAOther
0 comments
U.S. DOT/FAA - Acknowledgement LetterFAAOther
0 comments
U.S. DOT/FAA - Acknowledgement LetterFAAOther
0 comments
U.S. DOT/FAA - Request for InformationFAAOther
0 comments
Mountain Air Cargo, Inc. - Exemption/RulemakingFAAOther
0 comments
U.S. DOT/FAA - Acknowledgement LetterFAAOther
0 comments
ROAR Over Texas Inc. - Exemption/RulemakingFAAOther
0 comments
U.S. DOT/FAA - Acknowledgement LetterFAAOther
0 comments
Anonymous - Exemption/RulemakingFAAOther
0 comments
JC Ag Solutions, LLC - Exemption/RulemakingFAAOther
0 comments
Certain Estrogen-Androgen Combination Drugs; Drugs for Human Use; Drug Efficacy Study Implementation; Amendment and Opportunity for HearingFDANotice
0 comments
Drug and Device Manufacturer Communications With Payors Formulary Committees and Similar Entities - Questions and Answers - Guidance for Industry and Review StaffFDAOther
0 comments
Interim ResponseFDAOther
0 comments
ComplaintFDAOther
0 comments
ComplaintFDAOther
0 comments
ComplaintFDAOther
0 comments
ComplaintFDAOther
0 comments
ComplaintFDAOther
0 comments
ComplaintFDAOther
0 comments
ComplaintFDAOther
0 comments
ComplaintFDAOther
0 comments
Citizen Petition from HQ Pharma (Shanghai) Co., Ltd.FDAOther
0 comments
Response Letter from FDA CDER to HQ Pharma (Shanghai) Co., Ltd.FDAOther
0 comments
Citizen Petition from Animal Defenders InternationalFDAOther
0 comments
Acknowledgement Letter from FDA DMB to Animal Defenders InternationalFDAOther
0 comments
Citizen Petition from Evan H. CoutureFDAOther
0 comments
Acknowledgement Letter from FDA DMB to Evan H. CoutureFDAOther
0 comments
Citizen Petition from Windels Marx Lane & Mittendorf, LLPFDAOther
0 comments
Acknowledgement Letter from FDA DMB to Windels Marx Lane & Mittendorf, LLPFDAOther
0 comments
Reference 1 - Draft Guidance on Dabrafenib MesylateFDASupporting & Related Material
0 comments
Reference 2 - Criteria for waiver of evidence of in vivo bioavailability or bioequivalenceFDASupporting & Related Material
0 comments
Reference 3 - Prescribing Information for TAFINLARFDASupporting & Related Material
0 comments
Reference 4 - Petition to request a change from a listed drugFDASupporting & Related Material
0 comments